P-type ATPases catalyze the active transport of cations and phospholipids across biological membranes. Members of this large family are involved in a range of fundamental cellular processes. To date, a substantial number of P-type ATPase inhibitors have been characterized, some of which are used as drugs. In this work a library of natural compounds was screened and we first identified curcuminoids as plasma membrane H + -ATPases inhibitors in plant and fungal cells. We also found that some of the commercial curcumins contain several curcuminoids. Three of these were purified and, among the curcuminoids, demethoxycurcumin was the most potent inhibitor of all tested P-type ATPases from fungal (Pma1p; H + -ATPase), plant (AHA2; H + -ATPase) and animal (SERCA; Ca 2+ -ATPase) cells. All three curcuminoids acted as non-competitive antagonist to ATP and hence may bind to a highly conserved allosteric site of these pumps. Future research on biological effects of commercial preparations of curcumin should consider the heterogeneity of the material.
Introduction
P-type ATPases constitute a large superfamily of enzymes that carry out pivotal processes in all kingdoms of life by pumping specific cations or phospholipids across lipid bilayers at the expense of one ATP molecule per cycle [1] [2] [3] [4] [5] . The characteristic structural features of the catalytic subunit of P-type ATPase are three cytosolic domains, comprising an actuator (A), a nucleotide binding (N), and a phosphorylation domain (P) that together with a multispan transmembrane domain, and in some cases additional regulatory cytosolic domains (R) at the N-or C-terminal ends [6] [7] [8] [9] [10] [11] make up the pump functional unit. They are classified into five major families, P1 to P5-ATPases, which are further subdivided into subgroups based on their sequence motifs and transport specificity [1, 2, 12] . A hallmark of the P-type ATPases is the presence of an aspartic acid residue in a highly conserved motif DKTGT of the P-domain, which is phosphorylated by ATP during the reaction cycle [2] [3] [4] 13] . Some P-type ATPases are associated with transport of essential micronutrients such as Zn 2+ and Cu
2+
(P1B-ATPases) and Ca 2+ (P2A and P2B-ATPases). Cation transport by others generates an electrochemical gradient that in some cases can be used for secondary active transport e.g. plasma membrane (PM) H + -ATPases in plants and fungi (P3A) and Na + /K + -ATPases in animals (P2C), and for active transport of lipids (P4-ATPases) [2, 3, 14, 15] . Because of their critical role in the regulation of cellular metabolism, malfunctions of P-type ATPases are associated with a number of widespread diseases [16, 17] .
Due to their important role in health and disease there is considerable interest in identification of drugs targeting P-type ATPases and, to date, a substantial number of P-type ATPase inhibitors have been synthesized or identified from natural sources [17] . Omeprazole is an example of a synthetic drug that is used to treat dyspeptic conditions and ouabain is a well known natural compound used to treat congestive heart failure [18, 19] . Mipsagargin, a prodrug of thapsigargin, a specific inhibitor of the sarco/encoplasmatic Ca 2+ -ATPase (SERCA), has in clinical trials showed promising effects against hepatocellular carcinoma [20] . Recently an allosteric activator of SERCA has been shown to lower fasting blood glucose, improve glucose tolerance and ameliorate hepatosteatosis in ob/ob mice [21] .
Fungal P-type ATPases such as the PM H + -ATPase are considered as attractive targets for the development of new antifungal agents [22] [23] [24] . The potential of such agents might include preservation of food and conservation of crops. At the present, however, no promising lead compound has been found [17, [25] [26] [27] ].
Inhibition of plant PM H + -ATPase directly affects closure of the stomatal pores, which is used as a protective measure to help plants overcome extreme stress, such as drought, salinity or invasions of pathogens [28] [29] [30] [31] [32] . A well-described modulator of the PM H + -ATPase in the guard cells surrounding the stomatal pore through which plants breath is the fungal toxin fusicoccin [33, 34] . In conclusion, identification and characterization of inhibitors of P-type ATPases can be expected to be valuable for the discovery of drug leads and of new agents to protect plants and crops towards infections and for further studies on the structure and function of the P-type ATPase.
Turmeric rhizomes obtained from either Curcuma longa L. or C. zanthorrhiza Roxb. have been used in traditional Indian (Ayurveda), Arabian and Chinese medicine for millennia [35, 36] . The rhizomes are still included in the European Pharmacopoeia. The coloring and biological activities have been related to the presence of mainly curcuminoids with curcumin (CM, 1), demethoxycurcumin (DMCM, 2), bisdemethoxycurcumin (BDCM, 3) as the main constituents and small amounts of other curcuminoids like cyclocurcumin [37, 38] . Even though some methods have been developed to separate these compounds on a preparative as well as an analytical scale, most commercially available samples consist of a mixture of curcuminoids [39] [40] [41] . Despite that the chemical community has been aware of the presence of several curcuminoids, the biological community has only to a limited extent paid attention to this fact when examining the biological activities of curcumin preparations.
Several publications assign the biological activity of turmeric rhizomes to CM, the main component of curcumin preparations. CM is believed to possess antibacterial and antifungal activity [42] , to have antimalarial effects as well as serving in protection against other parasites [43, 44] . In a mouse model for Alzheimers disease CM decreases the level of oxidized proteins and interleukin 1-β [45] . A number of potential target molecules for CM have been identified such as growth factors, transcription factors, protein kinases, other enzymes (such as cyclooxygenase 2 and 5 lipoxygenase) [36] as well as P-type-ATPases [46] [47] [48] [49] . Curcumin is undergoing phase I clinical trials as an adjuvant to improve the effectiveness of chemotherapeutic against breast cancer [50] .
In our efforts to screen for small molecule inhibitors of P-type ATPases, and in particular PM H + -ATPases, we screened commercial curcumin preparations. An analysis of the product revealed that demethoxycurcumin (DMCM), one of the major curcuminoids in turmeric accounts for 15-20%, CM for about 60% and BDCM for about 5%. Many studies have used commercial curcumin preparations apparently without paying attention to the heterogeneity of the material. We have examined in detail the effects of the different curcuminoids CM, DMCM and BDCM. The compounds were tested on PM H + -ATPases from plant (AHA2), yeast (Pma1p) and the Ca 2+ -ATPase (SERCA), and they were all found to inhibit these P-type pumps as noncompetitive ATP antagonists. Furthermore, we were able to demonstrate antigrowth effects by DMCM on Saccharomyces cerevisiae. This effect is likely to be caused by the inhibition of the essential PM H + -ATPase.
Materials and Methods

Chemical Materials
Curcumin (cat #C7727), dibenzylideneacetone (cat#246425) and 6-shogaol (cat #39303) were purchased from Sigma-Aldrich. 
Yeast Strain and Plasmids
Procedures for Experiments with SERCA
Sarcoplasmic reticulum vesicles, prepared from the leg and back muscles of rabbits, were used to obtain purified SERCA1a by extraction with a low concentration of deoxycholate according to established methods [59] . The resulting membrane fragments were used for enzymatic assays to test the effect of the curcuminoid compounds on ATP hydrolysis spectrophotometrically by NADH oxidation with an ATP regenerating system [60] .
Screening of Chemical Library
A number of 160 compounds were chosen from an in-house library of natural products. The compounds represent a diversity of chemical structures and physicochemical properties important for drugs, such as molecular weight < 500, clogP < 5 and tPSA < 100 [61] . All the tested compounds are listed in S1 
Isolation of Curcumin Analogs
Curcumin (CM, 1), demethoxycurcumin (DMCM, 2), bisdemethoxycurcumin (BDCM, 3) and 1,5-dihydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-4,6-heptadien-3-one (6) were purified as previous described [39, 62] (Fig 1) . Tetrahydrocurcumin (5), 1,7-bis(3',4'-dimethoxyphenyl)-4,4-dimethyl-1,6-heptadien-3,5-dione (7) and 1-(3',4'-dimethoxyphenyl)-4,4-dimethyl-7-(4'-methoxyphenyl)-1,6-heptadien-3,5-dione (8) were synthesized as described by Takeuchi et al. [63] (Fig 1) . The compounds were dissolved in DMSO and stored as small aliquots at-20°C.
PM H + -ATPase Assays
ATPase activity was determined by the Baginski assay as described previously [64] using 2-5 μg of PM protein. The assays were performed at 30°C in 300 μL volumes with 3 mM ATP, pH 6.5, for determination of AHA2 activity, or with 5 mM ATP, pH 5.9 for Pma1p activity. The assay medium 20 mM MOPS, 50 mM KNO 3 (to inhibit vacuolar ATPase), 5 mM NaN 3
Fig 1.
Curcumin analogs employed in this study. Curcumin (Sigma-Aldrich) was initially identified as a hit in an in vitro screen for inhibitors of the plasma membrane H + -ATPase. Curcumin (CM, 1) demethoxycurcumin (DMCM, 2), bisdemethoxycurcumin (BDCM, 3) and 1,5-dihydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-4,6-heptadien-3-one (6) were then purified as previous described [39, 62] . 6-shogaol (4) and dibenzylideneacetone (9) were obtained from Sigma-Aldrich. Tetrahydrocurcumin (5), 1,7-bis(3',4'-dimethoxyphenyl)-4,4-dimethyl-1,6-heptadien-3,5-dione (7) and 1-(3',4'-dimethoxyphenyl)-4,4-dimethyl-7-(4'-methoxyphenyl)-1,6-heptadien-3,5-dione (8) were synthesized as previously described in the literature [63] .
(to inhibit mitochondrial ATPase), 3.5 mM Na 2 MoO 4 (to inhibit acid phosphatase), 1 mM Mg 2+ free in solution, and the indicated concentrations of MgATP. IC 50 values for compound inhibition were determined by pre incubating PM with different concentrations of compound for 30 min at room temperature. For kinetics studies, the concentration of ATP was varied between 0.125 and 8 mM using an ATP regenerating system (5 mM phosphoenolpyruvate and 50 μg/mL pyruvate kinase).
Proton Pumping Assay
Inside-out vesicles were created from spinach plasma membranes by adding the detergent Brij-58 to the buffer. Proton transport into the vesicles was determined as described [58, 64] by monitoring fluorescence quenching (excitation at 412 nm, emission at 480 nm) of 9-amino-6-chloro-2-methoxyacridine (ACMA). The reaction medium contained 20 mM MOPS-KOH, pH 7.0, 40 mM K 2 SO 4 , 25 mM KNO 3 , 2 mM ATP, 1 μM ACMA, 60 nM valinomycin and 0.05% (w/v) Brij-58. Proton pumping reactions were started by the addition of MgSO 4 to a final concentration of 2 mM, and the proton gradient was collapsed by the addition of 10 μM nigericin.
Drop Tests
Transformed yeast cells, cultured on synthetic galactose (SG) agar medium supplemented with adenine 40 μg/mL and L-histidine 20 μg/mL (SGAH plates) for 3 days at 30°C, were suspended in H 2 O to 1x solution (OD 660 = 1). Serial dilutions of 0.1, 0.01, 0.001 x of the cells were then prepared and spotted adjacently onto synthetic minimal media plates containing either 2% galactose or 2% glucose at pH 5.5 (SGAH or SDAH), incorporated with different concentrations of tested compound. Growth results were recorded after incubation for 3 days at 30°C. Minimum inhibitory concentrations (MIC values) were determined as the lowest concentrations of compounds where no visible growth of cells was observed.
Protein Determination
Protein concentrations were determined by the method of Bradford employing bovine serum albumin as a reference [65] .
Kinetic and Dose-Response Analysis
The kinetic of inhibition for DMCM was determined by monitoring the rate of ATP hydrolysis reaction in the presence of increasing ATP substrate concentration. All kinetic data were gathered from experiments performed in the cuvette-based assay, as described above. The data were used in Hanes-Woolf analysis followed by fitting to the appropriate Michaelis-Menten inhibition equation (competitive, noncompetitive, uncompetitive, or mix type inhibition). The kinetic parameters V max , K m , K i were estimated by nonlinear regression using GraphPad Prism 5.0 (GraphPad Software Inc.). For evaluation of inhibitor potency, IC 50 values were calculated by using the equation:
where A is the observed % ATPase activity in the presence of compound; C, the compound concentration; IC 50 , the concentration that caused 50% inhibition of the maximal compound effect; and H, the slope factor.
Statistics
All experiments were performed at least three independent times, each with three replicates. Values are presented as mean ± S.E.M. unless otherwise stated. P-values were calculated oneor two-way analysis of variance (ANOVA) followed by Bonferroni post-hoc testing using GraphPad Prism 5.0. P < 0.05 was considered statistically significant. Ã , p < 0.05; ÃÃ , p < 0.01; ÃÃÃ , p < 0.001.
Results
Screening of a Chemical Library for Inhibitors of PM H + -ATPases
A library of 160 natural products was screened for the ability to inhibit fungal (Pma1p) and plant (AHA2) PM H + -ATPase. The selected library encompassed a diversity of structures possessing a broad range of physicochemical properties important for drug action. From the initial data, curcumin (Sigma-Aldrich, cat #C7727) was identified as the best hit, showing more than 95% of the inhibition at 100 μM as compared to the control (S1 Fig Only three of the curcumin analogs: CM, DMCM and BDCM significantly inhibited these enzymes (Fig 2A) , among which DMCM (2) exhibited the most pronounced effect, while CM and BDCM were about half as effective. Interestingly these compounds were equally effective inhibitors of both plant and yeast PM H + -ATPase enzymes, whereas the other tested analogs did not exhibit any effect on AHA2 and Pma1p activity (Fig 2A) . These preliminary structure activity observations suggest that the central keto-enol moiety and surrounding conjugated double bonds are chemical features important for the inhibitory activity towards the PM H + -ATPases.
Inhibitory Effects on PM H + -ATPases by DMCM
To further evaluate the specific inhibitory activity of the three analogs on PM H + -ATPase activity, concentration response curves were generated (Fig 2B) . The activity of AHA2 was reduced by DMCM in a concentration-dependent manner with IC 50 of 18.7 μM, which is a more potent effect than that of CM and BDMC (IC 50 , 60.4 and 76.7 μM, respectively) ( Table 1 ). The same pattern of inhibitory potencies was observed for Pma1p with IC 50 values of 28.9, 76.1 and 90.6 μM, respectively (Fig 2B and Table 1 ). Interestingly, the structure of DMCM containing a methoxy moiety at only one of the two phenyl rings significantly enhanced the inhibitory activity (IC 50 value) by a 2-to 4-fold lower value, in comparison to CM which has two p-hydroxy-m-methoxyphenyl rings or BDCM with only p-hydroxyphenyl rings. The inhibition curves were fitted with a variable slope factor H. The H factor for DMCM inhibition of AHA2 and Pma1p was 2.4 and 1.5 respectively, in contrast to the numbers for CM and BDCM that were close to 1. This suggests a cooperative binding of DMCM. All values are presented as the mean of three independent experiments ± S.E., and indicated in μM. -ATPases utilize the energy released from ATP phosphorylation followed by hydrolysis to pump protons across the plasma membrane generating an electrochemical gradient required for nutrient and water uptakes by plant and fungi [28, 34] . Because of the tight coupling between ATP hydrolysis and proton transport [67, 68] , we next studied the effects of curcuminoids on H + pumping activity by using PM vesicles isolated from spinach leaves. Fig 3 shows the quenched fluorescence caused by proton accumulation inside the vesicles in response to treatment with the three curcuminoids. Again DMCM exhibited the strongest effect compared to CM and BDCM. The H + pumping activity was dramatically reversed in the concentration range 5-20 μM of DMCM. The order of efficiency among the three compounds (Fig 3) was similar to the above ATP hydrolysis results and therefore strongly confirms the inhibition effects on PM H + -ATPases of these compounds.
Mechanism of DMCM Inhibition
To Table 2 ). We estimated the K i to be 14.7 and 27.7 μM for AHA2 and Pma1p respectively (Table 3) , corresponding to the previously estimated IC 50 values. These kinetic data suggest that DMCM behaves as a noncompetitive inhibitor of ATP.
Effects of DMCM on SERCA Activity ). From these experiments we extract an IC 50 value of 2.6 μM from the dose dependent response curve in comparison to CM and BDCM (IC 50 , 3.9 and 9.4 μM, respectively) (Fig 5 and Table 1 ). Thus the inhibitory effects of these compounds on SERCA were found to be stronger, but with retention of the same order of potencies as observed on AHA2 and Pma1p pumps. These data, in conjunction with the report of an inhibitory effect of curcumin on Na + /K + -ATPase [49] suggest that DMCM may modulate different members of Ptype ATPases in vitro by a common mechanism binding to a highly conserved region [69] .
Effects of Curcuminoids on Yeast Growth
As PM H + -ATPases are essential for the growth of fungi, we used the yeast strain RS-72 as a model to test the potency of the curcuminoids. In S. cerevisiae strain RS-72, expression of the endogenous PM H + -ATPase PMA1 is dependent on the addition of galactose to the media enabling the possibility of expressing and testing other PM H + -ATPase homologues. RS-72 transformed with an empty vector (as control) is not able to grow in glucose containing media (Fig 6) . RS-72 expressing either Arabidopsis homologues (wild-type: AHA2 and a truncated mutation: aha2Δ92) or wild-type PMA1 from S. cerevisiae were grown on media containing increasing concentrations of the three compounds in question. The enzyme aha2Δ92 is an activated form of AHA2 due to the removal of an autoinhibitory domain. Yeast cells dependent on heterologously expressed aha2Δ92 grow better than cells expressing wild-type AHA2, which grow poorly compared to yeast expressing wild-type Pma1p. All the tested strains showed sensitivity to the added compounds (Fig 6) . Again DMCM was the most effective inhibitor compared to CM and BDCM. Minimum inhibitory concentrations (MIC values) were (Fig 6 and  Table 3 ) demonstrating a convincing positive correlation between the enzyme assay and the growth experiments.
Discussion
PM H + -ATPase Inhibition and the Antifungal Effect of Curcuminoids
Curcuminoids originate from rhizomes of C. longa. The dried and grounded rhizomes are commonly used as spices in food and in health products. Many studies have reported that the curcuminoids possess antifungal activity [42] , and also have synergistic properties with other well known agents [70, 71] . However, very few studies have compared the activities of the three major curcuminoids. The present study provides insight into the mode of action of three curcuminoids and demonstrates an inhibitory effect on Pma1p, correlated with reduced fungal growth. This result is fully consistent with a recent report defining the pH differences in Candida culture medium in presence and absence of CM, which suggested curcumin to regulate H + -extrusion by PM ATPases [72] . In addition, we show that curcuminoids also inhibit plant PM H + -ATPase. This effect could be of interest in order to protect plants during pathogenic infections. In plants, several pathogenic bacteria enter the leaf through the stomatal pore and closure of the stomatal pore by inhibition of the PM H + -ATPase is one of the defense mechanisms exploited by plants upon recognition of pathogenic bacteria [29] [30] [31] [32] . Also pretreatment of plants with curcumin revealed fungicidal activity towards selected plant pathogenic fungi [73] , if this effect was due to a direct effect on the fungi or the ability to infect via the stomatal pore is not known. The low toxicity of the curcuminoids towards humans makes them interesting agents for developments of antifungal agents. The higher activity of DMCM makes this the most interesting lead compound to be used in organic agriculture and food preservation.
DMCM Is a Potent SERCA Pump Inhibitor
Inhibitory effects of CM and some of its analogs, including BDCM, on SERCA have been broadly investigated. In the present study we compared the effect of DMCM with CM and BDCM on the basis of Ca 2+ -ATPase activity per se of the SERCA pump. Interestingly, DMCM exhibited the strongest effect on SERCA among the tested curcuminoids with an IC 50 value of 2.6 μM compared to IC 50 values of 3.9 and 9.4 μM for CM and BDCM, respectively. Numerous studies to date have shown the pharmacological safety and efficacy of CM, however, it exhibits poor bioavailability due to fast metabolism primarily through reduction followed by conjugation to glucuronic or sulfuric acid [74] . Although the structural difference between CM and DMCM is a minor one (namely the presence or absence of a methoxy group), the chemical characteristics of DMCM are more stable [75] . Our data might inspire to future investigations of the performance of DMCM in prostate and colorectal cancers related to SERCA activity [76, 77] .
Structure Activity Relationships of Curcuminoids on ATPase Activity
In the current study, we have investigated the structure activity relationship of curcumin analogs and discovered molecular characteristics important for the effects against ATPase. The study has included the role of the hydroxyl aryl moiety, conjugated double bonds and the central keto-enol moiety. Although a previous study on SERCA has emphasized the importance of phenolic -OH at the 4 position and the non-essential role of o-methoxy group on the aryl ring [46] , our data showed the more complicated interaction with this methoxy group. DMCM with only one methoxy group significantly enhanced the inhibitory activity, whereas CM and BDCM possessing two or no methoxy groups, respectively, were less active. This finding might be related to the asymmetrical nature of DMCM in contrast to CM and BDCM. In DMCM the two oxygen atoms at the aliphatic chain (O-3 and O-5) are not chemically identical and form a predominant tautomer B2 [78] . The o-methoxy group influences the electron density on the central keto-enol group, which in turn might affect its binding ability to ATPase proteins.
Curcuminoids Are General P-Type ATPase Inhibitors
Inhibitors of P-type ATPases are important drugs [17] . Of particular importance are digoxin, ouabain [18, 19, 79] , thapsigargin [80, 81] and cyclopiazonic acid [82] , which are all derived from natural products. Turmeric, a spice with multiple pharmacological utilities [83] to consider DMCM and other curcuminoids as general P-type ATPase inhibitors that also modulate other members of the P-type ATPase superfamily. Our kinetic study revealed that DMCM is a noncompetitive antagonist to ATP and hence may bind to a highly conserved allosteric site of these pumps. This is accordance with the previous findings for CM binding on SERCA [46] [47] [48] . Additionally our data suggested that DMCM might bind in a cooperative manner or that two binding sites are present. A similar observation is made in [48] where the authors suggest that binding of curcumin to the Ca 2+ -ATPase induces a conformational change, which then blocks the ATP binding.
In conclusion, our study reveals that curcuminoids target P-type ATPases present in fungi, plants and animals, and have antifungal properties. In spite of the inhibition of P-type ATPases they are not toxic for mammals [85] , which can be explained by fast metabolism into glucuronides and sulfates [74, 86] . The structure activity relationship analysis of curcumin analogs against these ATPases provides crucial information for drug design and discovery process. Among the active curcuminoids present in the commercial preparation of curcumin, DMCM is the most potent inhibitor of all tested P-type ATPases. Future studies on biological effects of curcuminoids thus should consider the heterogeneity of the commercial samples of the compounds. 
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